RBC Life Sciences, Inc. (RBCL.OB) has reported a 45% increase in net sales, with net sales totaling $7,857,000 in the third quarter of 2007. Whereas net sales in the same period last year totaled $5,405,000, this represents a significant increase in company operations. Furthermore, RBC’s net earnings increased over 700% in the third quarter of 2007, moving from $80,000 and $0.00 per share in the third quarter of 2006 to $672,000; or $0.03 per share.
RBC’s net sales for the first nine months of 2007 increased over 24 percent to $20,397,000 compared to net sales of $16,416,000 in the same period last year. Likewise, the company’s net earnings increased more then 300 percent to $1,507,000, or $0.07 per share, compared to net earnings of $335,000, or $0.01 per share, in the same period last year.
Clinton Howard, Chairman and CEO of RBC Life Sciences, commented “The significant increase in net earnings this year has resulted from strong sales growth in both our nutritional supplements segment and our medical products segment. The growth of our international nutritional supplement sales under license agreements has been particularly strong. Also, comparative earnings for the first nine months of last year were lower due to expenses associated with opening an office in Asia in 2006.”
Let us hear your thoughts below: